MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 276 filers reported holding MYRIAD GENETICS INC in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $28,195,000 | -30.7% | 827,803 | -21.5% | 0.84% | -40.1% |
| Q3 2014 | $40,692,000 | -4.2% | 1,055,014 | -3.3% | 1.41% | -4.3% |
| Q2 2014 | $42,471,000 | -31.6% | 1,091,227 | -40.0% | 1.47% | -39.5% |
| Q1 2014 | $62,137,000 | +92.5% | 1,817,401 | +18.1% | 2.44% | +86.1% |
| Q4 2013 | $32,282,000 | +9802.5% | 1,538,685 | +10989.6% | 1.31% | +8633.3% |
| Q3 2013 | $326,000 | – | 13,875 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |